As part of our focus around World Antibiotic Awareness Week (13–19 November) we spoke to Professor Jonathan Cooke, a pharmacologist and pharmacist based in the UK who holds a special interest in antimicrobial resistance. He shares his thoughts on this pressing issue below:
Browsing: Disease Area > Bacterial
In this infographic we summarize the clinical candidates reported by the WHO – indicating which diseases they are active (or possibly active) against, whether they’re considered innovative and which Phase the trials are currently in.
For the first time, researchers have employed an electroceutical technique – using electric field-based dressings – to manage biofilm infections. Understanding how this technique could influence host–microbe interactions will be pivotal in its application to wound healing in humans.
Read our note from the Editor and browse some of our top, exclusive content on antimicrobial resistance in line with World Antibiotic Awareness Week.
In this piece, the authors give an overview of anti-virulence drugs, designed to selectively target key virulence factors of pathogenic bacteria, and one strategy for new antimicrobials.
Scientists have unveiled the molecular architecture of two key proteins required for bacillus cell wall elongation. Inhibiting their interaction could provide a new mode of action for antibiotics against highly resistant bacteria.
Using live predatory bacteria as an alternative to traditional antibiotics had been suggested and studied over the last several years. Here we discuss some aspects of predatory bacteria that highlight their potential to serve as a possible antibiotic in the future.
New research has highlighted the burden of group B streptococcal disease in women and infants worldwide, highlighting the need for a vaccine.